glp-1 receptor agonist fatigue management strategies Muscle loss and GLP-1R agonists use | Acta Diabetologica GLP-1 Fatigue | Why Does
Description
[DOI] [PubMed] [Google Scholar] 30.Sun F, Chai S, Yu K, Quan X, Yang Z, Wu S, Zhang Y, Ji L, Wang J, Shi L
doi: 10.1111/apt.15316
Smits MM, Holst JJ
Additionally, GLP-1 acts directly and indirectly on the Wnt/-catenin pathway by reducing the mRNA levels of sclerostin, a known inhibitor of bone formation [55]
Sattar, N., Deanfield, J
Metformin is now increasingly being used in combination with new incretin-based therapies: glucagon-like peptide 1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors [46], both of which enhance pancreatic beta cell function
